SE9404568L - Användning av inositoltrisfosfat för beredning av läkemedel - Google Patents

Användning av inositoltrisfosfat för beredning av läkemedel

Info

Publication number: SE9404568L
Authority: SE; Sweden
Prior art keywords: drug preparation; inositol trisphosphate; trisphosphate; inositol; drug
Prior art date: 1994-12-30

Application number

SE9404568A

Other languages

Unknown language ( )

English (en)

Swedish (sv)

Other versions

SE9404568D0 (sv

Inventor

Matti Siren

Original Assignee

Perstorp Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-12-30

Filing date

1994-12-30

Publication date

1996-07-01

1994-12-30 Application filed by Perstorp Ab filed Critical Perstorp Ab

1994-12-30 Priority to SE9404568A priority Critical patent/SE9404568L/

1994-12-30 Publication of SE9404568D0 publication Critical patent/SE9404568D0/xx

1995-12-22 Priority to PCT/SE1995/001585 priority patent/WO1996020715A1/en

1995-12-22 Priority to AT95942373T priority patent/ATE247474T1/de

1995-12-22 Priority to DE69531554T priority patent/DE69531554T2/de

1995-12-22 Priority to JP8520899A priority patent/JPH10511677A/ja

1995-12-22 Priority to AU43619/96A priority patent/AU4361996A/en

1995-12-22 Priority to EP95942373A priority patent/EP0794786B1/de

1996-07-01 Publication of SE9404568L publication Critical patent/SE9404568L/

Links

MMWCIQZXVOZEGG-UHFFFAOYSA-N 1,4,5-IP3 Natural products OC1C(O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(O)C1OP(O)(O)=O MMWCIQZXVOZEGG-UHFFFAOYSA-N 0.000 title abstract 3
MMWCIQZXVOZEGG-XJTPDSDZSA-N D-myo-Inositol 1,4,5-trisphosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H](O)[C@@H]1OP(O)(O)=O MMWCIQZXVOZEGG-XJTPDSDZSA-N 0.000 title abstract 3
239000003814 drug Substances 0.000 title abstract 2
229940079593 drug Drugs 0.000 title 1
230000002001 anti-metastasis Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biochemistry (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

SE9404568A 1994-12-30 1994-12-30 Användning av inositoltrisfosfat för beredning av läkemedel SE9404568L (sv)

Priority Applications (7)

Application Number	Priority Date	Filing Date	Title
SE9404568A SE9404568L (sv)	1994-12-30	1994-12-30	Användning av inositoltrisfosfat för beredning av läkemedel
PCT/SE1995/001585 WO1996020715A1 (en)	1994-12-30	1995-12-22	The use of inositoltrisphosphate for the preparing of medicaments
AT95942373T ATE247474T1 (de)	1994-12-30	1995-12-22	Verwendung von inosittriphosphat zur herstellung von arzneimitteln
DE69531554T DE69531554T2 (de)	1994-12-30	1995-12-22	Verwendung von inosittriphosphat zur herstellung von arzneimitteln
JP8520899A JPH10511677A (ja)	1994-12-30	1995-12-22	イノシトール三燐酸の薬剤調製への使用
AU43619/96A AU4361996A (en)	1994-12-30	1995-12-22	The use of inositoltrisphosphate for the preparing of medicaments
EP95942373A EP0794786B1 (de)	1994-12-30	1995-12-22	Verwendung von inosittriphosphat zur herstellung von arzneimitteln

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9404568A SE9404568L (sv)	1994-12-30	1994-12-30	Användning av inositoltrisfosfat för beredning av läkemedel

Publications (2)

Publication Number	Publication Date
SE9404568D0 SE9404568D0 (sv)	1994-12-30
SE9404568L true SE9404568L (sv)	1996-07-01

Family

ID=20396521

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE9404568A SE9404568L (sv)	1994-12-30	1994-12-30	Användning av inositoltrisfosfat för beredning av läkemedel

Country Status (7)

Country	Link
EP (1)	EP0794786B1 (de)
JP (1)	JPH10511677A (de)
AT (1)	ATE247474T1 (de)
AU (1)	AU4361996A (de)
DE (1)	DE69531554T2 (de)
SE (1)	SE9404568L (de)
WO (1)	WO1996020715A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR0215102A (pt) *	2001-12-13	2004-11-03	Vital Health Sciences Pty Ltd	Transporte transdermal de compostos, formulação tópica, método para melhorar a absorção da pele, método para a terapia de reposição hormonal, uso de um ou mais derivados de fosfato de um composto hidróxi farmacêutico em um sistema de aplicação transdermal, sistema de aplicação transdermal, método para aplicação de um composto hidróxi farmacêutico a um indivìduo e para melhorar a eficácia de uma formulação
AU2002950713A0 (en)	2002-08-09	2002-09-12	Vital Health Sciences Pty Ltd	Carrier
MX2007015949A (es)	2005-06-17	2008-03-07	Vital Health Sciences Pty Ltd	Un vehiculo que comprende uno o mas derivados de fosfato de di- y/o mono-(agentes de transferencia de electrones) o complejos de los mismos.
US10071030B2 (en)	2010-02-05	2018-09-11	Phosphagenics Limited	Carrier comprising non-neutralised tocopheryl phosphate
JP5806287B2 (ja)	2010-03-30	2015-11-10	フォスファジェニクスリミティド	経皮送達パッチ
WO2012122586A1 (en)	2011-03-15	2012-09-20	Phosphagenics Limited	New composition
MX383940B (es)	2015-12-09	2025-03-14	Phosphagenics Ltd	Formulación farmacéutica que contiene tocol fosfato.
JP7198754B2 (ja)	2016-12-21	2023-01-04	アベーチョバイオテクノロジーリミテッド	方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3336583A1 (de) *	1983-09-26	1985-04-25	Udo Dr. 8400 Regensburg Ehrenfeld	Erzeugnis zur diagnose und therapie von malignen tumoren
US4952396A (en) *	1986-11-19	1990-08-28	Linus Pauling Institute Of Science & Medicine	Method of using phytic acid for inhibiting tumor growth

1994
- 1994-12-30 SE SE9404568A patent/SE9404568L/ not_active Application Discontinuation
1995
- 1995-12-22 AT AT95942373T patent/ATE247474T1/de not_active IP Right Cessation
- 1995-12-22 WO PCT/SE1995/001585 patent/WO1996020715A1/en not_active Ceased
- 1995-12-22 DE DE69531554T patent/DE69531554T2/de not_active Expired - Fee Related
- 1995-12-22 JP JP8520899A patent/JPH10511677A/ja active Pending
- 1995-12-22 AU AU43619/96A patent/AU4361996A/en not_active Abandoned
- 1995-12-22 EP EP95942373A patent/EP0794786B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP0794786B1 (de)	2003-08-20
DE69531554D1 (de)	2003-09-25
ATE247474T1 (de)	2003-09-15
AU4361996A (en)	1996-07-24
WO1996020715A1 (en)	1996-07-11
JPH10511677A (ja)	1998-11-10
SE9404568D0 (sv)	1994-12-30
DE69531554T2 (de)	2004-06-17
EP0794786A1 (de)	1997-09-17

Similar Documents

Publication	Publication Date	Title
NO20101190L (no)	1999-10-22	Anvendelse av buprenorfin i fremstillingen av et medikament
EP0552256A4 (de)	1994-04-27
IT8619625A0 (it)	1986-03-04	Composizioni farmaceutiche per inalazione.
NO174877C (no)	1994-07-27	Fremgangsmåte for fremstilling av et legemiddel med antitumorvirkning
FI901787A0 (fi)	1990-04-09	Menetelmä lääkkeenvälityskoostumuksen valmistamiseksi
DK0869808T3 (da)	2006-11-13	Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation
LV11985A (lv)	1998-03-20	Noteiktu cistina atvasinajumu farmakologiska izmantosana
MX9207394A (es)	1993-07-30	Esteroides de 17-espirofuran-3'-ilideno.
DE3880667D1 (de)	1993-06-03	Ampulle zur gesteuerten verabreichung eines heilmittels.
DK376188A (da)	1989-01-07	Farmaceutisk dosisenhed
CZ282732B6 (cs)	1997-09-17	Substituované 1,2,3,4-tetrahydrocyklopent/b/indoly, 1,2,3,3a,4,8a-hexahydrocyklopent/b/indoly a příbuzné sloučeniny, meziprodukty a způsob jejich přípravy a jejich použití jako léčiv
SE9404568D0 (sv)	1994-12-30	The use of inositoltrisphosphate for the preparing of medicaments
SE9303853L (sv)	1995-05-23	Användning av en inositoltrisfosfatester för beredning av läkemedel
FI98127B (fi)	1997-01-15	Menetelmä stabiloidun farmaseuttisen koostumuksen valmistamiseksi
AR059965A2 (es)	2008-05-14	Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
SE9002342D0 (sv)	1990-07-04	Medicament
SE9303289L (sv)	1995-04-09	Användning av inositoltrisfosfat för beredning av läkemedel
FI101600B1 (fi)	1998-07-31	Menetelmä farmaseuttisen formulaation valmistamiseksi
SE9504594L (sv)	1997-06-22	Användning av en ester av inositoltrisfosfat för beredning av läkemedel
SE9303855L (sv)	1995-05-23	Användning av en inositoltrisfosfatester för beredning av ett smärtstillande läkemedel
SE9203296L (sv)	1994-05-06	Användning av inositolreisfosfat för beredning av läkemedel
IL97509A0 (en)	1992-06-21	Lipid lowering compositions comprising bambuterol
ZA897549B (en)	1990-07-25	Medicament for the treatment of diseases caused by retroviruses
FR2390421A1 (fr)	1978-12-08	1-acyl-2-hydroxy-1,3-diaminopropanes a titre de nouveaux medicaments
CA2033975A1 (en)	1991-02-01	Use of .beta.-receptor blocking agents

Legal Events

Date

Code

Title

Description

2002-10-01

NAV

Patent application has lapsed

Ref document number: 9404568-9

Format of ref document f/p: F